Stealth BioTherapeutics (MITO) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free MITO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBolt Biotherapeutics Incmoney.usnews.com - April 17 at 1:29 PMSTEALTH BIOTHERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR ELAMIPRETIDE FOR THE TREATMENT OF BARTH SYNDROMEprnewswire.com - April 8 at 8:00 AMSonnet BioTherapeutics Holdings Inc.wsj.com - February 22 at 1:06 PMIovance Biotherapeutics Inc (IOVA)investing.com - February 9 at 10:34 PMBarinthus Biotherapeutics PLC ADR BRNSmorningstar.com - November 23 at 12:09 AMLab Notes: Vittoria Biotherapeutics raises $15M; Madrigal adds to C-suitebizjournals.com - November 17 at 7:58 PMIovance Biotherapeutics Inc IOVAmorningstar.com - November 16 at 6:16 PMSAB Biotherapeutics Inc SABSmorningstar.com - November 9 at 7:50 PMCalidi Biotherapeutics Inc (CLDI)investing.com - October 30 at 10:52 PMStealth BioTherapeutics achieves target enrolment in PMM therapy trialmsn.com - September 12 at 9:14 AMStealth BioTherapeutics Completes Target Enrollment in Global Phase 3 NuPOWER Trial in Patients with Primary Mitochondrial Myopathybenzinga.com - September 11 at 11:08 PMAs Needham biotech struggles with FDA, patients with an ultra-rare disease are waitingbizjournals.com - September 6 at 9:19 AMB-2 stealth bombers to return to flight after 5-month delaynews.yahoo.com - June 2 at 9:41 PMWealth with stealthdailymail.co.uk - May 16 at 2:15 AMGlobal Mitochondrial Myopathy Diagnosis & Treatment Market Size by Type (itochondrial Myopathy Diagnosis) Forecast from 2023 to 2028marketwatch.com - March 27 at 5:36 PMChain Reaction raises $70M, emerges from stealth to launch chips designed to compute encrypted datatechcrunch.com - February 25 at 5:33 PMWill Roper's Istari, Inc. emerges from stealth mode to transform digital engineering and accelerate Industry 4.0finance.yahoo.com - February 19 at 12:33 AMStealth BioTherapeutics Corp Announces Completion of Mergerfinance.yahoo.com - November 16 at 6:59 PMmarketbeat.com - November 16 at 6:01 AMStealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)finance.yahoo.com - November 1 at 8:03 AMAs Trump Org trial looms, lawyers to look out for 'stealth jurors'news.yahoo.com - October 27 at 5:41 PMStealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholdersfinance.yahoo.com - October 7 at 7:30 PMStealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Eventsfinance.yahoo.com - September 15 at 9:20 PMShort Volatility Alert: Stealth BioTherapeutics Corpmsn.com - August 5 at 1:03 PMBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Stealth BioTherapeutics Corp (Nasdaq - MITO), Romeo Power, Inc. (NYSE - RMO), One Medical (Nasdaq - ONEM), Hanger, Inc. (NYSE - HNGR)benzinga.com - August 1 at 3:58 PMStealth BioTherapeutics To Be Taken Private In All-cash Dealnasdaq.com - August 1 at 2:13 PMStealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transactionfinance.yahoo.com - August 1 at 9:12 AMMITO: Stealth BioTherapeutics Considering Offer, While Progress Continuesfinance.yahoo.com - July 26 at 4:24 PMStealth BioTherapeutics Gets Buyout Offermarketwatch.com - June 28 at 4:29 PMStealth Bio gains after non-binding buyout offerseekingalpha.com - June 27 at 1:41 PMStealth BioTherapeutics Board Receives Preliminary Proposal Letternasdaq.com - June 27 at 1:41 PMStealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposalfinance.yahoo.com - June 27 at 1:41 PMmarketbeat.com - June 27 at 6:58 AMStealth Granted Pre-NDA Meeting For Elamipretide To Treat Barth Syndromemarkets.businessinsider.com - June 14 at 9:38 AMStealth Bio rises on pre-NDA meeting for candidate targeting rare heart conditionseekingalpha.com - June 14 at 9:38 AMStealth BioTherapeutics Granted Pre-NDA Meeting for Elamipretide as a Potential Treatment for Barth Syndromefinance.yahoo.com - June 14 at 9:38 AMHealthcare Breakthroughs: NVAX, MITO, LMLLF, NMLSF; Life Sciences Leaders Report Latest Advances in Vaccines, Novel Therapeutics for Autism, Neurodegenerative, Oncology, and Glaucomafinance.yahoo.com - June 8 at 6:24 PMWhy Stealth BioTherapeutics Shares Are Surging Today?benzinga.com - June 8 at 9:54 AMStealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposiumfinance.yahoo.com - June 8 at 9:08 AMStealth Bio's elamipretide gets EMA orphan drug status for muscle disorderseekingalpha.com - May 31 at 10:19 AMStealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Myopathic Mitochondrial DNA Depletion Syndromefinance.yahoo.com - May 31 at 10:19 AMStealth BioTherapeutics Announces Data from the Phase 2 ReCLAIM-2 Study of Elamipretide in Geographic Atrophy at the Clinical Trials at the Summit Meeting 2022finance.yahoo.com - May 23 at 7:34 AMStealth Bio climbs on FDA’s Orphan Drug status for lead asset in muscular disorderseekingalpha.com - May 12 at 10:18 AMMITO: Positive Data Despite Miss for MITOmsn.com - May 3 at 12:17 PMStealth Bio slips as blindness trial fails to meet main goalseekingalpha.com - May 2 at 11:13 AMSTEALTH BIOTHERAPEUTICS ANNOUNCES DATA FROM RECLAIM-2 PHASE 2 TRIAL OF ELAMIPRETIDE IN GEOGRAPHIC ATROPHYfinance.yahoo.com - May 2 at 11:13 AMmarketbeat.com - May 2 at 7:26 AMStealth BioTherapeutics to raise $8.5M in equity financingseekingalpha.com - April 11 at 12:24 PMStealth BioTherapeutics Announces $8.5 Million in Equity Financingsfinance.yahoo.com - April 11 at 12:24 PMMITO: Stealth BioTherapeutics’ Treatments Gain Momentumfinance.yahoo.com - April 1 at 6:42 PM Get Stealth BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MITO and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… MITO Media Mentions By Week MITO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MITO News Sentiment▼0.000.44▲Average Medical News Sentiment MITO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MITO Articles This Week▼00▲MITO Articles Average Week Get Stealth BioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for MITO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ONCT News Today INDP News Today ITRM News Today LSTA News Today GDTC News Today ADXN News Today BFRG News Today DRRX News Today NRSN News Today SNSE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MITO) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmith“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stealth BioTherapeutics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
